EarSwitch’s Post

The upcoming FDA guidelines for pulse oximeters, while a step forward, may not go far enough to address racial bias in healthcare. Research shows pulse oximeters are three times more likely to miss dangerously low oxygen levels in Black patients than in white patients, leading to delayed care and worse outcomes. This disparity was especially evident during the COVID-19 pandemic when Black Americans faced higher mortality rates and delayed treatment, a trend also seen in the UK. Although the FDA plans to recommend testing oximeters on diverse populations, it may not require testing under real-world conditions that affect accuracy, such as poor circulation, which is more common in Black communities. Without this, oximeters could continue to fail those who need accurate readings the most. To truly solve this issue, the healthcare industry must prioritise developing more accurate, alternative vital signs monitoring tools that serve all patients equally. Only then can we ensure fair, reliable care for everyone. Read more ➡️ https://lnkd.in/eBMG6J8K #healthcare #digitalhealth #healthmonitoring

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics